Gene · 8352
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data. | J Neurosurg Pediatr | 2022 | 35535848 | PubTator, text mining | PubMed |
| Stable inheritance of H3.3-containing nucleosomes during mitotic cell divisions. | Nat Commun | 2022 | 35523900 | PubTator, text mining | PubMed |
Sensemaking by Employees in Essential versus Non-essential Professions During the COVID-19 Crisis: A Comparison of Effects of Change Communication and Disruption Cues on Mental Health, Through Interpretations of Identity Threats and Work Meaningfulness. | Manag Commun Q | 2022 | 35520537 | PubTator, text mining | PubMed |
| Lipid exposure activates gene expression changes associated with estrogen receptor negative breast cancer. | NPJ Breast Cancer | 2022 | 35508495 | PubTator, text mining | PubMed |
| Diffuse midline glioma H3K27M mutation in adult: A case report. | Ann Med Surg (Lond) | 2022 | 35495373 | PubTator, text mining | PubMed |
| The Profiles of Tet-Mediated DNA Hydroxymethylation in Human Gliomas. | Front Oncol | 2022 | 35494033 | PubTator, text mining | PubMed |
| Chk1 Inhibition Hinders the Restoration of H3.1K56 and H3.3K56 Acetylation and Reprograms Gene Transcription After DNA Damage Repair. | Front Oncol | 2022 | 35494003 | PubTator, text mining | PubMed |
| High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array. | J Proteomics | 2022 | 35489683 | PubTator, text mining | PubMed |
| Thoracic low grade glial neoplasm with concurrent H3 K27M and PTPN11 mutations. | Acta Neuropathol Commun | 2022 | 35484611 | PubTator, text mining | PubMed |
| Predicting Rural Women's Breast Cancer Screening Intention in China: A PLS-SEM Approach Based on the Theory of Planned Behavior. | Front Public Health | 2022 | 35480590 | PubTator, text mining | PubMed |
| Histone chaperone ASF1 acts with RIF1 to promote DNA end joining in BRCA1-deficient cells. | J Biol Chem | 2022 | 35472331 | PubTator, text mining | PubMed |
| Pediatric High Grade Glioma Classification Criteria and Molecular Features of a Case Series. | Genes (Basel) | 2022 | 35456430 | PubTator, text mining | PubMed |
| EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling. | Biomedicines | 2022 | 35453544 | PubTator, text mining | PubMed |
| Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase. | Nucleic Acids Res | 2022 | 35451487 | PubTator, text mining | PubMed |
| Mitotic drive in asymmetric epigenetic inheritance. | Biochem Soc Trans | 2022 | 35437581 | PubTator, text mining | PubMed |
| Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics. | Cancer Imaging | 2022 | 35436952 | PubTator, text mining | PubMed |
| Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome. | Nat Cancer | 2022 | 35422502 | PubTator, text mining | PubMed |
| 9p21.3 Microdeletion involving CDKN2A/2B in a young patient with multiple primary cancers and review of the literature. | Cold Spring Harb Mol Case Stud | 2022 | 35422439 | PubTator, text mining | PubMed |
| A Nutrient-Based Cellular Model to Characterize Acetylation-Dependent Protein-Protein Interactions. | Front Mol Biosci | 2022 | 35402505 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8352/papers?page=23